Suppr超能文献

含氧量心脏停搏液输送系统的评估

Evaluation of delivery systems for oxygenated cardioplegia.

作者信息

Landymore R W, Myers G

机构信息

Department of Surgery, Dalhousie University, Halifax, NS.

出版信息

Can J Surg. 1988 Sep;31(5):346-8.

PMID:3416247
Abstract

The oxygen-carrying capacity of four delivery systems for blood and crystalloid cardioplegia was evaluated: nonoxygenated crystalloid cardioplegia, crystalloid cardioplegia oxygenated with a bubbler system and with a membrane system and, finally, blood cardioplegia delivered by the Shiley-Buckberg system. The nonoxygenated crystalloid cardioplegic solution delivered 0.56 ml of oxygen/dl of solution, the bubbler oxygenating system delivered 3.2 ml/dl and the membrane oxygenating system made available 3.7 ml/dl. Blood cardioplegia delivered 4.2 ml/dl when oxygen-carrying capacity was corrected for the shift in the oxyhemoglobin dissociation curve that occurs with hypothermia. There appears to be no advantage between blood and oxygenated crystalloid cardioplegia with respect to the ability of these solutions to provide oxygen to the myocardium during ischemic arrest. However, the bubbler oxygenating system is superior to the membrane and blood delivery systems in that it could administer cold cardioplegia at any time during the operation. In contrast, the membrane and blood cardioplegia delivery systems both depend on integral heat exchangers which limit the delivery of cold cardioplegia to the period of hypothermia.

摘要

对四种血液及晶体心脏停搏液输送系统的携氧能力进行了评估

未氧合的晶体心脏停搏液、经鼓泡系统和膜系统氧合的晶体心脏停搏液,以及最后由希利-巴克伯格系统输送的血液心脏停搏液。未氧合的晶体心脏停搏液每分升溶液输送0.56毫升氧气,鼓泡氧合系统输送3.2毫升/分升,膜氧合系统可提供3.7毫升/分升。当针对低温时发生的氧合血红蛋白解离曲线偏移对携氧能力进行校正后,血液心脏停搏液输送4.2毫升/分升。就这些溶液在缺血性停搏期间向心肌提供氧气的能力而言,血液心脏停搏液和氧合晶体心脏停搏液之间似乎没有优势。然而,鼓泡氧合系统优于膜系统和血液输送系统,因为它可以在手术期间的任何时候给予冷心脏停搏液。相比之下,膜系统和血液心脏停搏液输送系统都依赖于完整的热交换器,这限制了冷心脏停搏液只能在低温期间输送。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验